GSK Gsk Plc

TIDMGSK

RNS Number : 6575P

GlaxoSmithKline PLC

11 February 2019

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
      ========================================================================================== 
 a)    Name                                   Mrs Denise Connor 
====  ======================================  ================================================== 
 b)    Position/status                        PCA of Mr Roger Connor (President, Global 
                                               Vaccines) 
====  ======================================  ================================================== 
 c)    Initial notification/                  Initial Notification 
        amendment 
====  ======================================  ================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================== 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================== 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================== 
 a)    Description of                          Ordinary shares of 25 pence each ('Ordinary 
        the financial                           Shares') 
        instrument 
                                                ISIN: GB0009252882 
====  ======================================  ================================================== 
 b)    Nature of the                          Transfer of 6,000 Ordinary Shares to spouse 
        transaction                            for nil consideration. 
 
                                               No change in beneficial ownership. 
====  ======================================  ================================================== 
 c)    Price(s) and volume(s)                   Price(s)                 Volume(s) 
====  ======================================   =======================  ====================== 
    GBP0.00                                                              6,000 
   ===================================================================  ====================== 
 
 d)    Aggregated information                 n/a (single transaction) 
==== 
  Aggregated volume 
   Price 
 ================================================================  ============================= 
 e)    Date of the transaction                2019-02-08 
====  ======================================  ================================================== 
 f)    Place of the transaction               n/a 
      ======================================  ================================================== 
 
 
       Details of PDMR/person closely associated with them 
        ('PCA') 
      ========================================================================================== 
 a)    Name                                   Mr Roger Connor 
====  ======================================  ================================================== 
 b)    Position/status                        President, Global Vaccines 
====  ======================================  ================================================== 
 c)    Initial notification/                  Initial Notification 
        amendment 
====  ======================================  ================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================== 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================== 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================== 
 a)    Description of                          Ordinary shares of 25 pence each ('Ordinary 
        the financial                           Shares') 
        instrument 
                                                ISIN: GB0009252882 
====  ======================================  ================================================== 
 b)    Nature of the                          Receipt of 6,000 Ordinary Shares from 
        transaction                            spouse for nil consideration. 
====  ======================================  ================================================== 
 c)    Price(s) and volume(s)                   Price(s)                 Volume(s) 
====  ======================================   =======================  ====================== 
    GBP0.00                                                              6,000 
   ===================================================================  ====================== 
 
 d)    Aggregated information                 n/a (single transaction) 
==== 
  Aggregated volume 
   Price 
 ================================================================  ============================= 
 e)    Date of the transaction                2019-02-08 
====  ======================================  ================================================== 
 f)    Place of the transaction               n/a 
      ======================================  ================================================== 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHLFLFFKLFXBBQ

(END) Dow Jones Newswires

February 11, 2019 07:38 ET (12:38 GMT)

Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024

Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024